SPL Mapping FHIR R5 Implementation Guide
0.2.1 - Build CI United States of America flag

SPL Mapping FHIR R5 Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.2.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions

Example Bundle: ExampleEstablishmentRegistration

Generated Narrative: Bundle ExampleEstablishmentRegistration

Bundle ExampleEstablishmentRegistration of type message

Entry 1 - fullUrl = http://example.org/MessageHeader/SampleEstablishmentRegistrationMessage

Resource MessageHeader:

Generated Narrative: MessageHeader SampleEstablishmentRegistrationMessage

event: LOINC 51725-0: Establishment registration

Sources

-Endpoint[x]
*http://example.org/

focus:

Entry 2 - fullUrl = http://example.org/Organization/ExampleEstablishmentRegistrant

Resource Organization:

Generated Narrative: Organization ExampleEstablishmentRegistrant

identifier: urn:oid:1.3.6.1.4.1.519.1/111111111

type: An organization that registers establishment organizations.

name: REGISTRANT SERVICES INC

Contacts

-NameTelecomAddress
*Charles Smith+1-703-362-1280;ext=1234, charles@anywhere.com123 IVY LANE ROAD SMITH FALLS MD 12345 USA

Entry 3 - fullUrl = http://example.org/Organization/ExampleEstablishment

Resource Organization:

Generated Narrative: Organization ExampleEstablishment

identifier: urn:oid:1.3.6.1.4.1.519.1/222222222

type: An organization that provides operations in the manufacturing of a product.

name: EXAMPLE ESTABLISHMENT INC.

Contacts

-NameTelecomAddress
*Charles Smith+011-703-362-1280, charles@anywhere.com123 IVY LANE ROAD SMITH FALLS MD 12345 USA

Generated Narrative: HealthcareService #ExampleEstablishmentOperation

providedBy: Organization EXAMPLE ESTABLISHMENT INC.

type: manufacture

serviceProvisionCode: manufactures human over-the-counter drug products produced under a monograph